Lux Selvanesan (@laxi9) 's Twitter Profile
Lux Selvanesan

@laxi9

Commercial cancer research scientist. Molecular diagnostics, molecular technology, MDx. Multi-Ethnic, Inter-faith respect..."b the change u want to see"

ID: 846178760

calendar_today25-09-2012 20:26:09

524 Tweet

223 Takipçi

1,1K Takip Edilen

Lux Selvanesan (@laxi9) 's Twitter Profile Photo

Took just 4 minutes to arrive in my wallet. So amazed with how fast it came #solana #bonk solana-bonus.info/?1891918919

Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC) Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place #AUA24 #EAU24 #IBCG24 #ASCO24 Designed by Amanda Myers

The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place  #AUA24 #EAU24 #IBCG24 #ASCO24

Designed by <a href="/AmandaMyersMD/">Amanda Myers</a>
Pacific Edge (@pacificedgeltd) 's Twitter Profile Photo

From Science to Clinical Utility: Cxbladder Monitor - #BladderCancer Surveillance for Patients with Urothelial Carcinoma. Dr Neal Shore, Dr Joshua Meeks, and Dr Tamer Aboushwareb, Chief Medical Officer, Pacific Edge: hubs.ly/Q02KjXGL0 (via UroToday.com)

From Science to Clinical Utility: Cxbladder Monitor - #BladderCancer Surveillance for Patients with Urothelial Carcinoma. Dr Neal Shore, Dr Joshua Meeks, and Dr Tamer Aboushwareb, Chief Medical Officer, Pacific Edge: hubs.ly/Q02KjXGL0 (via <a href="/urotoday/">UroToday.com</a>)
Lux Selvanesan (@laxi9) 's Twitter Profile Photo

Advancements in #BladderCancer treatment! updates, including immunotherapy & targeted therapy options Innovationshttps://www.onclive.com/view/park-and-grivas-expand-on-treatment-updates-in-bladder-cancer via @onclive#CancerResearch #Oncology #MedicalNews #Healthcare

Lux Selvanesan (@laxi9) 's Twitter Profile Photo

🎓𝐓𝐰𝐨 𝐠𝐫𝐞𝐚𝐭 𝟐𝟎𝟐𝟒-𝟐𝟓 𝐬𝐮𝐦𝐦𝐞𝐫 𝐢𝐧𝐭𝐞𝐫𝐧𝐡𝐢𝐩𝐬 𝐜𝐥𝐨𝐬𝐞 𝐓𝐎𝐃𝐀𝐘! 𝐚𝐭 Pacific Edge Cxbladder 🚨 Email CV & cover letter to [email protected]. Vit our Careers Hub at pacificedgedx.com/careers to learn about the experience from previous interns.

🎓𝐓𝐰𝐨 𝐠𝐫𝐞𝐚𝐭 𝟐𝟎𝟐𝟒-𝟐𝟓 𝐬𝐮𝐦𝐦𝐞𝐫 𝐢𝐧𝐭𝐞𝐫𝐧𝐡𝐢𝐩𝐬 𝐜𝐥𝐨𝐬𝐞 𝐓𝐎𝐃𝐀𝐘! 𝐚𝐭 <a href="/PacificEdgeLtd/">Pacific Edge</a> <a href="/Cxbladder/">Cxbladder</a>
🚨 Email CV &amp; cover letter to recruitment@pelnz.com. Vit our Careers Hub at pacificedgedx.com/careers to learn about the experience from previous interns.
Pacific Edge (@pacificedgeltd) 's Twitter Profile Photo

Celebrating success in style. Late last year we decided to mark the development of a new RNA/DNA sample stabilisation buffer - a significant operational and logistical milestone - with a brew of a different sort. Learn more: hubs.ly/Q031Lgdx0

Celebrating success in style. Late last year we decided to mark the development of a new RNA/DNA sample stabilisation buffer - a significant operational and logistical milestone - with a brew of a different sort. Learn more: hubs.ly/Q031Lgdx0
Lux Selvanesan (@laxi9) 's Twitter Profile Photo

I am taking part in relay for Life - Do something remarkable and get involved today! relayforlife.org.nz/lux-selvanesan #RelayForLifeNZ via Cancer Society of NZ

I am taking part in relay for Life - Do something remarkable and get involved today! relayforlife.org.nz/lux-selvanesan #RelayForLifeNZ via <a href="/NZCancerSo/">Cancer Society of NZ</a>
Pacific Edge (@pacificedgeltd) 's Twitter Profile Photo

Host Diane Newman and Pacific Edge Senior Medical Director Dr. Jay Jhaveri discuss key changes incorporated into the 2025 AUA/SUFU Microhematuria Guideline and the implications for clinical practice. The updated Guideline emphasizes refined risk stratification and suggests a more

Host Diane Newman and Pacific Edge Senior Medical Director Dr. Jay Jhaveri discuss key changes incorporated into the 2025 AUA/SUFU Microhematuria Guideline and the implications for clinical practice. The updated Guideline emphasizes refined risk stratification and suggests a more
UroToday.com (@urotoday) 's Twitter Profile Photo

Platform reduces unnecessary cystoscopies for hematuria patients. Dr. John Sfakianos discusses how Cxbladder is changing the game in microhematuria & #BladderCancer surveillance. With 99–100% NPV, Triage & Monitor tests help avoid unnecessary cystoscopies & personalize

Platform reduces unnecessary cystoscopies for hematuria patients. <a href="/DrJohnSfakianos/">Dr. John Sfakianos</a> discusses how <a href="/Cxbladder/">Cxbladder</a> is changing the game in microhematuria &amp; #BladderCancer surveillance. With 99–100% NPV, Triage &amp; Monitor tests help avoid unnecessary cystoscopies &amp; personalize
Cxbladder (@cxbladder) 's Twitter Profile Photo

Improving Diagnosis and Treatment of Microhematuria: Kaiser Permanente's Dr. Ronald Loo and Dr. Christopher Filson join Dr. Zachary Klaassen to discuss the real-world implementation of Cxbladder Triage within the Kaiser Health System for risk stratification, including the results

Improving Diagnosis and Treatment of Microhematuria: Kaiser Permanente's Dr. Ronald Loo and Dr. Christopher Filson join Dr. Zachary Klaassen to discuss the real-world implementation of Cxbladder Triage within the Kaiser Health System for risk stratification, including the results